Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacogenetics of alcoholism: a clinical neuroscience perspective.

× No keyword cloud information.

20 in total

1. Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins.

Authors: C A Prescott; K S Kendler
Journal: Am J Psychiatry Date: 1999-01 Impact factor: 18.112

Review 2. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.

Authors: Lara A Ray; Christina S Barr; Julie A Blendy; David Oslin; David Goldman; Raymond F Anton
Journal: Alcohol Clin Exp Res Date: 2011-09-06 Impact factor: 3.455

3. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.

Authors: Joel Gelernter; Ralitza Gueorguieva; Henry R Kranzler; Huiping Zhang; Joyce Cramer; Robert Rosenheck; John H Krystal
Journal: Alcohol Clin Exp Res Date: 2007-04 Impact factor: 3.455

4. A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans.

Authors: Lara A Ray; Kent E Hutchison
Journal: Alcohol Clin Exp Res Date: 2004-12 Impact factor: 3.455

5. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.

Authors: Lara A Ray; Kent E Hutchison
Journal: Arch Gen Psychiatry Date: 2007-09

6. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors: C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal: Proc Natl Acad Sci U S A Date: 1998-08-04 Impact factor: 11.205

7. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.

Authors: David W Oslin; Wade Berrettini; Henry R Kranzler; Helen Pettinati; Joel Gelernter; Joseph R Volpicelli; Charles P O'Brien
Journal: Neuropsychopharmacology Date: 2003-06-18 Impact factor: 7.853

8. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.

Authors: Raymond F Anton; Gabor Oroszi; Stephanie O'Malley; David Couper; Robert Swift; Helen Pettinati; David Goldman
Journal: Arch Gen Psychiatry Date: 2008-02

Review 3. Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds.

Authors: Christian S Hendershot
Journal: Addict Sci Clin Pract Date: 2014-09-13

3 in total

Pharmacogenetics of alcoholism: a clinical neuroscience perspective.

1. Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins.

Review 2. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.

3. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.

4. A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans.

5. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.

6. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

7. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.

8. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.

Review 9. Alcoholism: the dissection for endophenotypes.

Review 10. ALDH2, ADH1B, and ADH1C genotypes in Asians: a literature review.

Review 1. Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research.

2. A preclinical model for identifying rats at risk of alcohol use disorder.

Review 3. Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds.